SCHEMBL3163147

SCHEMBL3163147

CC(=O)NCCNc1cc(NCCNC(=O)c2cccc(C)c2)nc(-c2ccc(Cl)cc2)n1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.50
SMN1; SMN2 Q16637 2/20 0.50
KDM4E B2RXH2 2/20 0.50
KMT2A Q03164 3/20 0.49
MEN1 O00255 2/20 0.49
TP53 P04637 3/20 0.47
MAPT P10636 1/20 0.47
CTSL P07711 2/20 0.47
CTSS P25774 2/20 0.47
CTSK P43235 1/20 0.47
NPC1 O15118 1/20 0.45
RAB9A P51151 1/20 0.45
ADORA3 P0DMS8 1/20 0.45
IDE P14735 1/20 0.44
KCNK3 O14649 1/20 0.44
LMNA P02545 1/20 0.43
GRM5 P41594 1/20 0.43
MALT1 Q9UDY8 1/20 0.43
GAA P10253 1/20 0.43
CYP1A2 P05177 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3174346 0.90 NPC1 (0.53) ALDH1A1SMN1; SMN2KDM4EKMT2AMEN1
SCHEMBL3175775 0.89 ADORA3 (0.48) ALDH1A1SMN1; SMN2KDM4EKMT2AMEN1
SCHEMBL3172187 0.89 ALDH1A1 (0.54) ALDH1A1SMN1; SMN2KDM4EKMT2AMEN1
SCHEMBL3170831 0.89 L3MBTL1 (0.50) ALDH1A1SMN1; SMN2KMT2AMEN1TP53
SCHEMBL3163156 0.88 RAB9A (0.48) SMN1; SMN2KMT2AMEN1TP53MAPT
SCHEMBL3176983 0.87 ADORA3 (0.57) ALDH1A1SMN1; SMN2KDM4EKMT2AMEN1
SCHEMBL3164802 0.85 L3MBTL1 (0.52) ALDH1A1SMN1; SMN2KMT2AMEN1MAPT
SCHEMBL3172697 0.85 NPC1 (0.47) ALDH1A1SMN1; SMN2KDM4EKMT2AMEN1
SCHEMBL3174225 0.85 TP53 (0.43) ALDH1A1SMN1; SMN2KDM4EKMT2AMEN1
SCHEMBL3170845 0.84 ADORA3 (0.46) ALDH1A1SMN1; SMN2KMT2AMEN1TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1465631-B1 PYRIMIDINE A2B SELECTIVE ANTAGONIST COMPOUNDS, THEIR SYNTHESIS AND USE OSI PHARM INC (US) 2010-02-24 EP disclosed